Description:age1 is a distinguished venture capital firm that specializes in funding innovative companies focused on breakthroughs in the field of longevity. By identifying and investing in businesses that tackle the fundamental challenges associated with this rapidly evolving sector, age1 plays a pivotal role in promoting advancements that could significantly enhance human healthspan. The firm prides itself on collaborating with bold and contrarian founders, providing them with the support and resources necessary to build generational biotech companies. With a forward-thinking approach, age1 is committed to fostering the growth of transformative ideas that have the potential to reshape the future of longevity and biotechnology.